Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00112411 | Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics | PHASE2 | COMPLETED | - | — | — | Jun 30, 2005 | Sep 30, 2005 | Dec 8, 2021 | 9 | United States |
| Name | Type | Description |
|---|---|---|
| Bronchodilator | DRUG | - |
Inclusion Criteria: * Persistent asthma for a minimum of six months duration that has been stable for at least four weeks * Predicted FEV1 60-90% * Demonstration of 12% airway reversibility Exclusion Criteria: * Continuous requirement for beta-blockers, monoamine oxidase (MAO) inhibitors, tricycl...